28th October 2017
Medical cannabis or medical marijuana, are cannabis or marijuana that is recommended by
doctors for their patients. It has been claimed to be beneficial for people with Parkinson’s
Disease. However, its use is controversial, because support for its benefits is based on small
clinical studies. For more information go to : https://en.wikipedia.org/wiki/Medical_cannabis
The duration of medical cannabis use was an average of 19
months (between 2 and 36 months). The average daily dose
was 0.9g per day. The delivery of medical cannabis was
mainly by smoking cigarettes (in 80% of cases). The size of
the effect from the greatest effect to the least effect were for
reducing falls 0.89, pain relief 0.73, tremor 0.64, depression
0.64, muscle stiffness 0.62, and then sleep 0.60.
The most frequently reported adverse effects from medical cannabis were cough (35%) in
those who used medical cannabis by smoking it, and confusion and hallucinations, which
were each reported in 17% of people, causing 10% of patients to stop taking cannabis.
Reference : Clinical Neuropharmacology [2017] Oct 20 [Epub ahead of print] (Y.Balash,
L.Bar-Lev Schleider, A.D.Korczyn, H.Shabtai, J.Knaani, A.Rosenberg, Y.Baruch, R.
Djaldetti, N.Giladi, T.Gurevich)
Complete abstract : http://www.ncbi.nlm.nih.gov/pubmed/29059132
http://www.viartis.net/parkinsons.disease/news/171028.pdf
No comments:
Post a Comment